Home/Filings/4/A/0001654954-21-010802
4/A//SEC Filing

Raines William F III 4/A

Accession 0001654954-21-010802

CIK 0001644903other

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 1:42 PM ET

Size

7.1 KB

Accession

0001654954-21-010802

Insider Transaction Report

Form 4/AAmended
Period: 2021-03-12
Transactions
  • Award

    Common stock

    2021-03-12+5,0006,342 total
Holdings
  • Common stock

    (indirect: See footnote)
    3,774,582
Footnotes (2)
  • [F1]Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.
  • [F2]The number of shares of common stock beneficially owned by the Reporting Person includes: (i) 92,582 shares held of record by Board Investor Group II, LLC; and (ii) 3,682,000 Second Tranche Shares for which unrestricted voting rights have not yet vested. Mr. Raines, in his position as Chief Executive Officer of Board Investor Group II, LLC, has voting and dispositive control over securities held by Board Investor Group II, LLC. Mr. Raines disclaims beneficial ownership of securities held by Board Investors Group II, LLC except to the extent of his pecuniary interest therein, and disclaims beneficial ownership of the 3,682,000 Second Tranche Shares which are subject to the Voting Proxy agreements.

Issuer

cbdMD, Inc.

CIK 0001644903

Entity typeother

Related Parties

1
  • filerCIK 0001773698

Filing Metadata

Form type
4/A
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 1:42 PM ET
Size
7.1 KB